当前位置: 首页 > 期刊 > 《中国实用医药》 > 2010年第22期
编号:11931969
细胞周期蛋白依赖性激酶活化激酶与肿瘤(2)
http://www.100md.com 2010年8月5日 《中国实用医药》 2010年第22期
     参 考 文 献

    [1] 储琳,钱旻,严缘昌.细胞周期蛋白依赖性激酶活化激酶(CAK)的研究进展.生命科学,2006,18(2):127-132.

    [2] Talukder AH,Mishra SK,Mandal M,et al.MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, andregulates estrogen receptor transactivation functions.J Biol Chem,2003,278(13):11676-11685.

    [3] Shineng Zhang,Qiaojun He,Hui Peng,et al.MAT1-Modulated Cyclin-Dependent Kinase-Activating Kinase Activity Cross-Regulates Neuroblastoma Cell G1 Arrest and Neurite Outgrowth.CANCER RESEARCH 64, 2004,1:2977-2983.

    [4] Kayaselcuk F,Erkanli S,Bolat F,et al.Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters.Int J Gynecol Cancer,2006,16(1):402-408.

    [5] Application of laser capture microdissection and differential display technique for screening of pathogenic genes involved in endometrial carcinoma.International Journal of Gynecological Cancer, 2007,17(6):1224-1230.

    [6] Li Y,Jin G,Wang H,et al.Polymorphisms of CAK genes and risk for lung cancer: a case-control study in Chinese population.Lung Cancer,2007,58(2):171-183.

    [7] Lolli G,Johnson LN.CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs.Cell Cycle,2005,4(4):572-577.

    [8] Ali S, Heathcote DA, Kroll SH, et al.The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity.Cancer Res, 2009,69(15):6208-6215., http://www.100md.com(詹杉杉 袁伟 蔡敬怡)
上一页1 2